‌

US Patent 10774146 Treatment of eosinophil or mast cell related disorders

Patent 10774146 was granted and assigned to Celldex Therapeutics on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Celldex Therapeutics

Current Assignee

Celldex Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107741460

Date of Patent

September 15, 2020

Patent Application Number

162701160

Date Filed

February 7, 2019

Patent Citations

‌

US Patent 10189907 Polynucleotides encoding anti-KIT antibodies

‌

US Patent 10184007 Methods of treating a kit-associated cancer by administering anti-kit antibodies

‌

US Patent 10239943 Treatment of eosinophil or mast cell related disorders

Patent Citations Received

‌

US Patent 11891452 Anti-kit antibodies and uses thereof

‌

US Patent 11884699 Anti-KIT antibodies and uses thereof

Patent Primary Examiner

‌

John D. Ulm

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10774146 Treatment of eosinophil or mast cell related disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.